[Therapeutic agents for alleviation of muscle weakness in myasthenia gravis (cholinesterase inhibitors)].
D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D003964:Diaphragm / Q000187:drug effects; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007421:Intestine, Small / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D009157:Myasthenia Gravis / Q000188:drug therapy*; D011817:Rabbits; D011898:Ranidae; D051381:Rats
D002800:Cholinesterase Inhibitors
Therapeutika zur Linderung der Muskelschwäche bei Myasthenia gravis (Cholinesterase-Hemmer).